Bigul

Notice Of Board Meeting To Be Held On 11.11.2017 And Notice Of Trading Window

A meeting of the Board of Directors of the company will be held on Saturday, 11th November, 2017 to consider and approve, inter alia amongst items the Unaudited Financial Results for the quarter & six months period ended September 30, 2017. Further, pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the trading window of the...
02-11-2017
Bigul

Compliance Certificate For The Half Year Ended On September 30, 2017.

Pursuant to regulation 7(3) of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the compliance certificate for the half year ended on September 30, 2017.
13-10-2017
Bigul

Compliance Under Regulation 40(10) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Pursuant to Regulation 40(10)of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the certificate, received from a Company Secretary in Practice as required under Regulation 40(9) of said Regulations, for the half year ended September 30, 2017.
09-10-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv HUF
07-10-2017
Bigul

Shareholding for the Period Ended September 30, 2017

Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here
06-10-2017
Bigul

Statement Of Investor Complaints For The Quarter Ended September 30, 2017

Pursuant to Regulation 13(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Statement of Investor Complaints for the Quarter ended September 30, 2017 is attached.
04-10-2017
Bigul

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Nectar Lifesciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
29-09-2017
Bigul

Scrutinizer's Report

Please also find enclosed herewith the Consolidated Scrutinizer's Report for remote e-voting and Polling at AGM as per the provision of Section 108 and Section 109 of the Companies Act, 2013 and rules prescribed thereunder. The above is also uploaded on the website of the Company. All resolutions were passed with requisite majority, including the resolution of declaration of Final Dividend @ Re. 0.05/- per equity share (5% on the...
29-09-2017
Bigul

Proceedings Of 22ND Annual General Meeting Of The Company

Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith proceedings of Annual General Meeting held on September 28, 2017.
28-09-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv (HUF)
27-08-2017
Next Page
Close

Let's Open Free Demat Account